FDA Adverse Event Injury Summary report: N

WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

MDR report key: 3800776 · Received May 8, 2014

Report

Report Number
2134265-2014-02457
Event Type
Injury
Date Received
May 8, 2014
Date of Event
April 9, 2014
Report Date
April 11, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
MAF
PMA / PMN Number
P980033
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE AT TIME OF EVENT: 18 YEARS OR OLDER. (B)(4). DEVICE EVALUATED BY MFR: THE DEVICE WAS RETURNED FOR ANALYSIS. RETURNED FOR ANALYSIS WAS A DISTAL SECTION OF INNER LUMEN MEASURING 340MM. THE BROKEN END OF THE INNER SHOWED NO EVIDENCE OF STRETCHING. THE SECTION OF INNER WAS CURVED IN APPEARANCE AND NO OTHER ISSUES WERE NOTED. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE MOST PROBABLE ROOT CAUSE WAS UNABLE TO BE DETERMINED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT REMOVAL DIFFICULTY AND A SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE URETER. AN UNSPECIFIED SIZE WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM WAS SELECTED FOR USE, ADVANCED AND DEPLOYED TO TREAT THE LESION. THE STENT WAS DEPLOYED GOOD. HOWEVER, THE STENT "DIDN'T COME LOOSE" OF THE DELIVERY SYSTEM. THE FRAGMENT WAS LEFT INSIDE THE PATIENT AND WAS REMOVED VIA LAPAROSCOPIC SURGERY THE NEXT DAY. AFTER REMOVAL OF THE DELIVERY SYSTEM FRAGMENT THE STENT REMAINED IMPLANTED. THE PHYSICIAN INDICATED HE WAS FINE WITH THE OUTCOME OF THE STENTED URETER. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED AND PATIENT'S STATUS WAS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
279298 WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM STENT, CORONARY MAF BOSTON SCIENTIFIC - GALWAY UNK679

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention